Concepedia

Sheryl Koski

SK

Statistics

Publications

25

Citations

7.1K

H-Index

20

Active since

1971

Affiliations

University of Alberta(Current)

Ottawa Hospital

Princess Margaret Cancer Centre

CancerCare Manitoba

University of Ottawa

Sheryl Koski is an author at University of Alberta specializing in medicine, oncology, and colorectal cancer.

ORCID

Publications per year

1971–2024

25

Publications

25

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

Leonard B. Saltz, Stephen Clarke, Eduardo Díaz‐Rubio et al. · Journal of Clinical Oncology · 2008 · 3K citations · Full text

, , +12

Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment

Carla M. Prado, Vickie E. Baracos, Linda J. McCargar et al. · Clinical Cancer Research · 2009 · 1.1K citations

, , +17

Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer

Jim Cassidy, Stephen Clarke, Eduardo Díaz‐Rubio et al. · Journal of Clinical Oncology · 2008 · 864 citations · Full text

, , +14

Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer

Eric X. Chen, Derek J. Jonker, Jonathan M. Loree et al. · JAMA Oncology · 2020 · 398 citations · Full text

, , +17

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

Leonard B. Saltz, Stephen Clarke, Eduardo Díaz‐Rubio et al. · Journal of Clinical Oncology · 2023 · 243 citations

, , +12

1–5 of 25